Author

Melissa J. Joliat

Observed names: M. Joliat, Melissa J Joliat

Observed institutions: Eli Lilly (United States), Jackson Laboratory

OpenAlex ID: A5027300489

Duloxetine Increases Serotonin and Norepinephrine Availability in Healthy Subjects: A Double-Blind, Controlled Study

2003 · Stephan A Chalon, Luc-André Granier, et al. · Neuropsychopharmacology · 95

Safety of Subchronic Treatment with Fluoxetine for Major Depressive Disorder in Children and Adolescents

2004 · Mary Nilsson, Melissa J. Joliat, et al. · Journal of Child and Adolescent Psychopharmacology · 40

Establishment and characterization of a new osteogenic cell line (MOS-J) from a spontaneous C57BL/6J mouse osteosarcoma.

2003 · Melissa J Joliat, Syuji Umeda, et al. · PubMed · 29

Recurrence of symptoms of premenstrual dysphoric disorder after the cessation of luteal-phase fluoxetine treatment

2003 · Teri Pearlstein, Melissa J. Joliat, et al. · American Journal of Obstetrics and Gynecology · 26

Mechanisms of anemia in SHP-1 protein tyrosine phosphatase-deficient “viable motheaten” mice

2003 · Bonnie L Lyons, Michael A Lynes, et al. · Experimental Hematology · 22

Long-Term Treatment Outcomes of Depression With Associated Anxiety

2004 · Melissa J. Joliat, Mark E. Schmidt, et al. · The Journal of Clinical Psychiatry · 16

Absence of CD5 Dramatically Reduces Progression of Pulmonary Inflammatory Lesions in SHP-1 Protein-Tyrosine Phosphatase-Deficient ‘Viable Motheaten’ Mice

2002 · Melissa J Joliat, Pamela A Lang, et al. · Journal of Autoimmunity · 11

The Molecular Bases of Spontaneous Immunological Mutations in the Mouse and Their Homologous Human Diseases

2001 · Melissa J. Joliat, Leonard D. Shultz · Clinical Immunology · 10

T Cell Developmental Defects in ‘Viable Motheaten’ Mice Deficient in SHP-1 Protein-Tyrosine Phosphatase. Developmental Defects are Corrected in the Presence of Normal Hematopoietic-Origin Stromal Cells and by Exogenous IL-7

2002 · Sherri W Christianson, Dale L Greiner, et al. · Journal of Autoimmunity · 8

P.1.096 Remission rates in double-blind, placebo-controlled clinical trials of duloxetine with SSRI as a comparator

2003 · M. Thase, Y. Lu, et al. · European Neuropsychopharmacology · 7

Changes in Energy After Switching From Daily Citalopram, Paroxetine, or Sertraline to Once-Weekly Fluoxetine

2004 · Melissa J. Joliat, Eileen B. Brown, et al. · Journal of Clinical Psychopharmacology · 2

Autoimmunity, Immune Deficiency and Cancer: Multiple Roles of the Protein Tyrosine Phosphate SHP-1

2001 · Melissa J. Joliat · DigitalCommons (California Polytechnic State University)

Works count: 13

Citation count: 265

H-index: 8

I10-index: 8